Detail Information of Epigenetic Regulations
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0529 Transporter Info | ||||
Gene Name | SCN9A | ||||
Transporter Name | Voltage-gated sodium channel alpha Nav1.7 | ||||
Gene ID | |||||
UniProt ID | |||||
Epigenetic Regulations of This DT (EGR) | |||||
---|---|---|---|---|---|
Methylation |
|||||
Bladder cancer |
9 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SCN9A in bladder cancer | [ 1 ] | |||
Location |
5'UTR (cg19098619) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -2.33E+00 | Statistic Test | p-value: 5.18E-13; Z-score: -1.64E+01 | ||
Methylation in Case |
3.05E-01 (Median) | Methylation in Control | 7.11E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SCN9A in bladder cancer | [ 1 ] | |||
Location |
5'UTR (cg13425422) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.36E+00 | Statistic Test | p-value: 5.35E-06; Z-score: -1.28E+01 | ||
Methylation in Case |
6.31E-01 (Median) | Methylation in Control | 8.56E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SCN9A in bladder cancer | [ 1 ] | |||
Location |
5'UTR (cg18745035) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.20E+00 | Statistic Test | p-value: 5.53E-06; Z-score: -6.55E+00 | ||
Methylation in Case |
7.55E-01 (Median) | Methylation in Control | 9.04E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SCN9A in bladder cancer | [ 1 ] | |||
Location |
5'UTR (cg01790523) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.87E+00 | Statistic Test | p-value: 5.71E-04; Z-score: -4.01E+00 | ||
Methylation in Case |
2.54E-01 (Median) | Methylation in Control | 4.73E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SCN9A in bladder cancer | [ 1 ] | |||
Location |
5'UTR (cg14794191) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.14E+00 | Statistic Test | p-value: 7.04E-04; Z-score: -4.62E+00 | ||
Methylation in Case |
7.64E-01 (Median) | Methylation in Control | 8.70E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SCN9A in bladder cancer | [ 1 ] | |||
Location |
TSS1500 (cg02056098) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.24E+00 | Statistic Test | p-value: 4.68E-03; Z-score: -2.19E+00 | ||
Methylation in Case |
5.10E-01 (Median) | Methylation in Control | 6.31E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SCN9A in bladder cancer | [ 1 ] | |||
Location |
Body (cg27357229) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.99E+00 | Statistic Test | p-value: 4.19E-08; Z-score: -7.61E+00 | ||
Methylation in Case |
3.53E-01 (Median) | Methylation in Control | 7.02E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SCN9A in bladder cancer | [ 1 ] | |||
Location |
Body (cg19320612) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.27E+00 | Statistic Test | p-value: 7.54E-06; Z-score: -1.73E+01 | ||
Methylation in Case |
6.95E-01 (Median) | Methylation in Control | 8.80E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 9 |
Methylation of SCN9A in bladder cancer | [ 1 ] | |||
Location |
Body (cg07296661) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.17E+00 | Statistic Test | p-value: 2.17E-05; Z-score: -8.16E+00 | ||
Methylation in Case |
7.45E-01 (Median) | Methylation in Control | 8.75E-01 (Median) | ||
Studied Phenotype |
Bladder cancer [ ICD-11: 2C94] | ||||
Experimental Material |
Patient tissue samples | ||||
Breast cancer |
16 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SCN9A in breast cancer | [ 2 ] | |||
Location |
5'UTR (cg01790523) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.48E+00 | Statistic Test | p-value: 1.95E-12; Z-score: -2.89E+00 | ||
Methylation in Case |
3.09E-01 (Median) | Methylation in Control | 4.57E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SCN9A in breast cancer | [ 2 ] | |||
Location |
5'UTR (cg13425422) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.15E+00 | Statistic Test | p-value: 9.60E-11; Z-score: -2.69E+00 | ||
Methylation in Case |
7.35E-01 (Median) | Methylation in Control | 8.43E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SCN9A in breast cancer | [ 2 ] | |||
Location |
5'UTR (cg14794191) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.08E+00 | Statistic Test | p-value: 7.57E-08; Z-score: -1.43E+00 | ||
Methylation in Case |
7.91E-01 (Median) | Methylation in Control | 8.54E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SCN9A in breast cancer | [ 2 ] | |||
Location |
5'UTR (cg18745035) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.06E+00 | Statistic Test | p-value: 1.66E-07; Z-score: -1.11E+00 | ||
Methylation in Case |
8.48E-01 (Median) | Methylation in Control | 8.98E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SCN9A in breast cancer | [ 2 ] | |||
Location |
5'UTR (cg03466415) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.02E+00 | Statistic Test | p-value: 4.98E-05; Z-score: -6.34E-01 | ||
Methylation in Case |
8.10E-01 (Median) | Methylation in Control | 8.27E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SCN9A in breast cancer | [ 2 ] | |||
Location |
5'UTR (cg19098619) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.05E+00 | Statistic Test | p-value: 4.82E-02; Z-score: -3.43E-01 | ||
Methylation in Case |
4.28E-01 (Median) | Methylation in Control | 4.50E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SCN9A in breast cancer | [ 2 ] | |||
Location |
TSS1500 (cg22199615) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.42E+00 | Statistic Test | p-value: 8.89E-05; Z-score: 1.03E+00 | ||
Methylation in Case |
1.29E-01 (Median) | Methylation in Control | 9.03E-02 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SCN9A in breast cancer | [ 2 ] | |||
Location |
TSS1500 (cg24789128) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.02E+00 | Statistic Test | p-value: 1.47E-04; Z-score: -7.86E-02 | ||
Methylation in Case |
8.78E-02 (Median) | Methylation in Control | 8.91E-02 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 9 |
Methylation of SCN9A in breast cancer | [ 2 ] | |||
Location |
TSS1500 (cg02642021) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.02E+00 | Statistic Test | p-value: 2.98E-03; Z-score: 6.21E-02 | ||
Methylation in Case |
1.26E-01 (Median) | Methylation in Control | 1.24E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 10 |
Methylation of SCN9A in breast cancer | [ 2 ] | |||
Location |
TSS1500 (cg02056098) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.09E+00 | Statistic Test | p-value: 6.84E-03; Z-score: 8.18E-01 | ||
Methylation in Case |
7.16E-01 (Median) | Methylation in Control | 6.56E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 11 |
Methylation of SCN9A in breast cancer | [ 2 ] | |||
Location |
TSS200 (cg22528044) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.67E+00 | Statistic Test | p-value: 2.72E-04; Z-score: 6.51E-01 | ||
Methylation in Case |
3.21E-02 (Median) | Methylation in Control | 1.93E-02 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 12 |
Methylation of SCN9A in breast cancer | [ 2 ] | |||
Location |
TSS200 (cg18047082) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.23E+00 | Statistic Test | p-value: 4.07E-03; Z-score: 6.35E-01 | ||
Methylation in Case |
5.49E-02 (Median) | Methylation in Control | 4.48E-02 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 13 |
Methylation of SCN9A in breast cancer | [ 2 ] | |||
Location |
TSS200 (cg00394494) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.09E+00 | Statistic Test | p-value: 4.78E-02; Z-score: 6.05E-02 | ||
Methylation in Case |
1.53E-02 (Median) | Methylation in Control | 1.40E-02 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 14 |
Methylation of SCN9A in breast cancer | [ 2 ] | |||
Location |
Body (cg19320612) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.06E+00 | Statistic Test | p-value: 1.45E-06; Z-score: -1.43E+00 | ||
Methylation in Case |
8.03E-01 (Median) | Methylation in Control | 8.53E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 15 |
Methylation of SCN9A in breast cancer | [ 2 ] | |||
Location |
Body (cg07296661) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.05E+00 | Statistic Test | p-value: 1.76E-05; Z-score: -9.20E-01 | ||
Methylation in Case |
7.60E-01 (Median) | Methylation in Control | 7.98E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 16 |
Methylation of SCN9A in breast cancer | [ 2 ] | |||
Location |
Body (cg27357229) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.22E+00 | Statistic Test | p-value: 3.79E-05; Z-score: -1.77E+00 | ||
Methylation in Case |
4.85E-01 (Median) | Methylation in Control | 5.94E-01 (Median) | ||
Studied Phenotype |
Breast cancer [ ICD-11: 2C60-2C6Z] | ||||
Experimental Material |
Patient tissue samples | ||||
Colon cancer |
6 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SCN9A in colon adenocarcinoma | [ 3 ] | |||
Location |
5'UTR (cg06645921) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.09E+00 | Statistic Test | p-value: 9.68E-04; Z-score: 6.13E-01 | ||
Methylation in Case |
5.88E-01 (Median) | Methylation in Control | 5.41E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SCN9A in colon adenocarcinoma | [ 3 ] | |||
Location |
TSS1500 (cg15083845) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.04E+00 | Statistic Test | p-value: 4.85E-03; Z-score: -1.10E+00 | ||
Methylation in Case |
7.74E-01 (Median) | Methylation in Control | 8.04E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SCN9A in colon adenocarcinoma | [ 3 ] | |||
Location |
TSS200 (cg03240509) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.16E+00 | Statistic Test | p-value: 2.60E-03; Z-score: 2.10E+00 | ||
Methylation in Case |
5.76E-01 (Median) | Methylation in Control | 4.95E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SCN9A in colon adenocarcinoma | [ 3 ] | |||
Location |
Body (cg26572770) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.20E+00 | Statistic Test | p-value: 1.96E-04; Z-score: 1.45E+00 | ||
Methylation in Case |
6.52E-01 (Median) | Methylation in Control | 5.44E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SCN9A in colon adenocarcinoma | [ 3 ] | |||
Location |
Body (cg07223937) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.02E+00 | Statistic Test | p-value: 1.59E-03; Z-score: -1.16E+00 | ||
Methylation in Case |
8.66E-01 (Median) | Methylation in Control | 8.85E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SCN9A in colon adenocarcinoma | [ 3 ] | |||
Location |
Body (cg16909495) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.28E+00 | Statistic Test | p-value: 3.52E-03; Z-score: 2.53E+00 | ||
Methylation in Case |
5.18E-01 (Median) | Methylation in Control | 4.04E-01 (Median) | ||
Studied Phenotype |
Colon cancer [ ICD-11: 2B90] | ||||
Experimental Material |
Patient tissue samples | ||||
Colorectal cancer |
13 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SCN9A in colorectal cancer | [ 4 ] | |||
Location |
5'UTR (cg01790523) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.55E+00 | Statistic Test | p-value: 3.79E-20; Z-score: -4.57E+00 | ||
Methylation in Case |
4.60E-01 (Median) | Methylation in Control | 7.13E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SCN9A in colorectal cancer | [ 4 ] | |||
Location |
5'UTR (cg19098619) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.45E+00 | Statistic Test | p-value: 6.42E-18; Z-score: -5.69E+00 | ||
Methylation in Case |
5.92E-01 (Median) | Methylation in Control | 8.59E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SCN9A in colorectal cancer | [ 4 ] | |||
Location |
5'UTR (cg13425422) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.20E+00 | Statistic Test | p-value: 3.41E-13; Z-score: -7.75E+00 | ||
Methylation in Case |
7.59E-01 (Median) | Methylation in Control | 9.11E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SCN9A in colorectal cancer | [ 4 ] | |||
Location |
5'UTR (cg14794191) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.15E+00 | Statistic Test | p-value: 4.92E-11; Z-score: -5.95E+00 | ||
Methylation in Case |
8.02E-01 (Median) | Methylation in Control | 9.21E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SCN9A in colorectal cancer | [ 4 ] | |||
Location |
5'UTR (cg03466415) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.00E+00 | Statistic Test | p-value: 2.62E-03; Z-score: -1.86E-02 | ||
Methylation in Case |
9.30E-01 (Median) | Methylation in Control | 9.30E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SCN9A in colorectal cancer | [ 4 ] | |||
Location |
5'UTR (cg18745035) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.04E+00 | Statistic Test | p-value: 5.85E-03; Z-score: -3.40E-01 | ||
Methylation in Case |
8.86E-01 (Median) | Methylation in Control | 9.21E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SCN9A in colorectal cancer | [ 4 ] | |||
Location |
TSS1500 (cg24789128) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.16E+00 | Statistic Test | p-value: 1.61E-04; Z-score: 7.66E-01 | ||
Methylation in Case |
1.02E-01 (Median) | Methylation in Control | 8.81E-02 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SCN9A in colorectal cancer | [ 4 ] | |||
Location |
TSS1500 (cg02642021) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.06E+00 | Statistic Test | p-value: 9.81E-04; Z-score: 2.83E-01 | ||
Methylation in Case |
1.74E-01 (Median) | Methylation in Control | 1.65E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 9 |
Methylation of SCN9A in colorectal cancer | [ 4 ] | |||
Location |
TSS1500 (cg22199615) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.07E+00 | Statistic Test | p-value: 2.69E-03; Z-score: 2.17E-01 | ||
Methylation in Case |
8.51E-02 (Median) | Methylation in Control | 7.97E-02 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 10 |
Methylation of SCN9A in colorectal cancer | [ 4 ] | |||
Location |
Body (cg27357229) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.37E+00 | Statistic Test | p-value: 7.95E-16; Z-score: -6.01E+00 | ||
Methylation in Case |
5.76E-01 (Median) | Methylation in Control | 7.88E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 11 |
Methylation of SCN9A in colorectal cancer | [ 4 ] | |||
Location |
Body (cg07296661) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.14E+00 | Statistic Test | p-value: 8.13E-12; Z-score: -9.46E+00 | ||
Methylation in Case |
8.17E-01 (Median) | Methylation in Control | 9.31E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 12 |
Methylation of SCN9A in colorectal cancer | [ 4 ] | |||
Location |
Body (cg19320612) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.09E+00 | Statistic Test | p-value: 1.31E-09; Z-score: -4.39E+00 | ||
Methylation in Case |
8.51E-01 (Median) | Methylation in Control | 9.26E-01 (Median) | ||
Studied Phenotype |
Colorectal cancer [ ICD-11: 2B91] | ||||
Experimental Material |
Patient tissue samples | ||||
Hepatocellular carcinoma |
15 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SCN9A in hepatocellular carcinoma | [ 5 ] | |||
Location |
5'UTR (cg01790523) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.12E+00 | Statistic Test | p-value: 2.97E-04; Z-score: -6.52E-01 | ||
Methylation in Case |
4.51E-01 (Median) | Methylation in Control | 5.06E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SCN9A in hepatocellular carcinoma | [ 5 ] | |||
Location |
5'UTR (cg00612138) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.08E+00 | Statistic Test | p-value: 7.39E-03; Z-score: -3.91E-01 | ||
Methylation in Case |
5.93E-02 (Median) | Methylation in Control | 6.41E-02 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SCN9A in hepatocellular carcinoma | [ 5 ] | |||
Location |
5'UTR (cg03466415) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.00E+00 | Statistic Test | p-value: 1.23E-02; Z-score: -1.62E-01 | ||
Methylation in Case |
8.42E-01 (Median) | Methylation in Control | 8.45E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SCN9A in hepatocellular carcinoma | [ 5 ] | |||
Location |
TSS1500 (cg02067405) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 2.29E+00 | Statistic Test | p-value: 1.64E-13; Z-score: 5.47E+00 | ||
Methylation in Case |
3.88E-01 (Median) | Methylation in Control | 1.70E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SCN9A in hepatocellular carcinoma | [ 5 ] | |||
Location |
TSS1500 (cg24314549) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.24E+00 | Statistic Test | p-value: 2.46E-10; Z-score: -1.27E+00 | ||
Methylation in Case |
1.68E-01 (Median) | Methylation in Control | 2.08E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SCN9A in hepatocellular carcinoma | [ 5 ] | |||
Location |
TSS1500 (cg02056098) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.07E+00 | Statistic Test | p-value: 1.29E-03; Z-score: 8.71E-01 | ||
Methylation in Case |
7.93E-01 (Median) | Methylation in Control | 7.39E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SCN9A in hepatocellular carcinoma | [ 5 ] | |||
Location |
TSS1500 (cg02642021) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 2.56E-03; Z-score: -7.26E-02 | ||
Methylation in Case |
1.08E-01 (Median) | Methylation in Control | 1.10E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SCN9A in hepatocellular carcinoma | [ 5 ] | |||
Location |
TSS1500 (cg22199615) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.04E+00 | Statistic Test | p-value: 6.33E-03; Z-score: 1.07E-01 | ||
Methylation in Case |
7.62E-02 (Median) | Methylation in Control | 7.31E-02 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 9 |
Methylation of SCN9A in hepatocellular carcinoma | [ 5 ] | |||
Location |
TSS1500 (cg24789128) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.00E+00 | Statistic Test | p-value: 8.79E-03; Z-score: -9.17E-05 | ||
Methylation in Case |
6.00E-02 (Median) | Methylation in Control | 6.00E-02 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 10 |
Methylation of SCN9A in hepatocellular carcinoma | [ 5 ] | |||
Location |
Body (cg03922758) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.70E+00 | Statistic Test | p-value: 3.21E-18; Z-score: -1.37E+01 | ||
Methylation in Case |
4.69E-01 (Median) | Methylation in Control | 7.96E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 11 |
Methylation of SCN9A in hepatocellular carcinoma | [ 5 ] | |||
Location |
Body (cg16287284) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.67E+00 | Statistic Test | p-value: 3.91E-15; Z-score: -3.70E+00 | ||
Methylation in Case |
3.36E-01 (Median) | Methylation in Control | 5.61E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 12 |
Methylation of SCN9A in hepatocellular carcinoma | [ 5 ] | |||
Location |
Body (cg08382534) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.25E+00 | Statistic Test | p-value: 9.36E-13; Z-score: -3.58E+00 | ||
Methylation in Case |
6.68E-01 (Median) | Methylation in Control | 8.32E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 13 |
Methylation of SCN9A in hepatocellular carcinoma | [ 5 ] | |||
Location |
Body (cg19062099) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.41E+00 | Statistic Test | p-value: 9.12E-11; Z-score: -1.78E+00 | ||
Methylation in Case |
2.54E-01 (Median) | Methylation in Control | 3.59E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 14 |
Methylation of SCN9A in hepatocellular carcinoma | [ 5 ] | |||
Location |
Body (cg07296661) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.03E+00 | Statistic Test | p-value: 3.30E-04; Z-score: -8.74E-01 | ||
Methylation in Case |
8.26E-01 (Median) | Methylation in Control | 8.50E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 15 |
Methylation of SCN9A in hepatocellular carcinoma | [ 5 ] | |||
Location |
Body (cg27357229) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.06E+00 | Statistic Test | p-value: 1.15E-02; Z-score: -5.96E-01 | ||
Methylation in Case |
6.21E-01 (Median) | Methylation in Control | 6.60E-01 (Median) | ||
Studied Phenotype |
Hepatocellular carcinoma [ ICD-11: 2C12.02] | ||||
Experimental Material |
Patient tissue samples | ||||
Lung adenocarcinoma |
8 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SCN9A in lung adenocarcinoma | [ 6 ] | |||
Location |
5'UTR (cg19098619) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.14E+00 | Statistic Test | p-value: 4.08E-03; Z-score: -1.96E+00 | ||
Methylation in Case |
6.63E-01 (Median) | Methylation in Control | 7.55E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SCN9A in lung adenocarcinoma | [ 6 ] | |||
Location |
5'UTR (cg14794191) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.03E+00 | Statistic Test | p-value: 1.71E-02; Z-score: -1.31E+00 | ||
Methylation in Case |
8.52E-01 (Median) | Methylation in Control | 8.79E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SCN9A in lung adenocarcinoma | [ 6 ] | |||
Location |
5'UTR (cg01790523) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.08E+00 | Statistic Test | p-value: 2.11E-02; Z-score: -1.03E+00 | ||
Methylation in Case |
4.91E-01 (Median) | Methylation in Control | 5.31E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SCN9A in lung adenocarcinoma | [ 6 ] | |||
Location |
5'UTR (cg13425422) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.04E+00 | Statistic Test | p-value: 4.10E-02; Z-score: -2.54E+00 | ||
Methylation in Case |
8.46E-01 (Median) | Methylation in Control | 8.81E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SCN9A in lung adenocarcinoma | [ 6 ] | |||
Location |
TSS1500 (cg02056098) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.20E+00 | Statistic Test | p-value: 1.89E-05; Z-score: 2.70E+00 | ||
Methylation in Case |
8.06E-01 (Median) | Methylation in Control | 6.70E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SCN9A in lung adenocarcinoma | [ 6 ] | |||
Location |
TSS1500 (cg24789128) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.27E+00 | Statistic Test | p-value: 3.72E-02; Z-score: 2.35E+00 | ||
Methylation in Case |
1.14E-01 (Median) | Methylation in Control | 9.03E-02 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SCN9A in lung adenocarcinoma | [ 6 ] | |||
Location |
TSS200 (cg00394494) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.60E+00 | Statistic Test | p-value: 1.03E-02; Z-score: 2.97E+00 | ||
Methylation in Case |
5.05E-02 (Median) | Methylation in Control | 3.15E-02 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SCN9A in lung adenocarcinoma | [ 6 ] | |||
Location |
Body (cg07296661) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.05E+00 | Statistic Test | p-value: 6.12E-04; Z-score: -2.16E+00 | ||
Methylation in Case |
8.42E-01 (Median) | Methylation in Control | 8.80E-01 (Median) | ||
Studied Phenotype |
Lung adenocarcinoma [ ICD-11: 2C25.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Pancretic ductal adenocarcinoma |
16 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SCN9A in pancretic ductal adenocarcinoma | [ 7 ] | |||
Location |
5'UTR (cg15759056) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 3.81E+00 | Statistic Test | p-value: 2.90E-33; Z-score: 7.87E+00 | ||
Methylation in Case |
1.82E-01 (Median) | Methylation in Control | 4.77E-02 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SCN9A in pancretic ductal adenocarcinoma | [ 7 ] | |||
Location |
5'UTR (cg07969045) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.03E+00 | Statistic Test | p-value: 3.43E-13; Z-score: -1.40E+00 | ||
Methylation in Case |
8.79E-01 (Median) | Methylation in Control | 9.03E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SCN9A in pancretic ductal adenocarcinoma | [ 7 ] | |||
Location |
5'UTR (cg03861633) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.09E+00 | Statistic Test | p-value: 6.02E-06; Z-score: -1.07E+00 | ||
Methylation in Case |
7.24E-01 (Median) | Methylation in Control | 7.90E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SCN9A in pancretic ductal adenocarcinoma | [ 7 ] | |||
Location |
TSS1500 (cg23331484) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.33E+00 | Statistic Test | p-value: 2.92E-22; Z-score: 3.31E+00 | ||
Methylation in Case |
5.36E-01 (Median) | Methylation in Control | 4.02E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SCN9A in pancretic ductal adenocarcinoma | [ 7 ] | |||
Location |
TSS1500 (cg18939241) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.23E+00 | Statistic Test | p-value: 6.07E-07; Z-score: 1.65E+00 | ||
Methylation in Case |
6.94E-01 (Median) | Methylation in Control | 5.65E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SCN9A in pancretic ductal adenocarcinoma | [ 7 ] | |||
Location |
TSS1500 (cg04539957) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.16E+00 | Statistic Test | p-value: 1.34E-06; Z-score: 1.46E+00 | ||
Methylation in Case |
7.34E-01 (Median) | Methylation in Control | 6.34E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SCN9A in pancretic ductal adenocarcinoma | [ 7 ] | |||
Location |
TSS1500 (cg04460557) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.06E+00 | Statistic Test | p-value: 2.41E-02; Z-score: -4.97E-01 | ||
Methylation in Case |
4.63E-01 (Median) | Methylation in Control | 4.88E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 8 |
Methylation of SCN9A in pancretic ductal adenocarcinoma | [ 7 ] | |||
Location |
1stExon (cg19561774) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.01E+00 | Statistic Test | p-value: 2.37E-02; Z-score: 8.27E-01 | ||
Methylation in Case |
8.77E-01 (Median) | Methylation in Control | 8.64E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 9 |
Methylation of SCN9A in pancretic ductal adenocarcinoma | [ 7 ] | |||
Location |
Body (cg20669572) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.24E+00 | Statistic Test | p-value: 1.17E-08; Z-score: 1.80E+00 | ||
Methylation in Case |
6.97E-01 (Median) | Methylation in Control | 5.63E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 10 |
Methylation of SCN9A in pancretic ductal adenocarcinoma | [ 7 ] | |||
Location |
Body (cg02057782) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.27E+00 | Statistic Test | p-value: 1.81E-07; Z-score: 1.39E+00 | ||
Methylation in Case |
5.25E-01 (Median) | Methylation in Control | 4.13E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 11 |
Methylation of SCN9A in pancretic ductal adenocarcinoma | [ 7 ] | |||
Location |
Body (cg23301539) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 3.85E-04; Z-score: -4.19E-01 | ||
Methylation in Case |
9.35E-01 (Median) | Methylation in Control | 9.40E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 12 |
Methylation of SCN9A in pancretic ductal adenocarcinoma | [ 7 ] | |||
Location |
Body (cg08065122) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.35E+00 | Statistic Test | p-value: 7.13E-04; Z-score: 1.42E+00 | ||
Methylation in Case |
7.03E-01 (Median) | Methylation in Control | 5.21E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 13 |
Methylation of SCN9A in pancretic ductal adenocarcinoma | [ 7 ] | |||
Location |
Body (cg17778888) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 1.26E-03; Z-score: -3.63E-01 | ||
Methylation in Case |
8.94E-01 (Median) | Methylation in Control | 9.06E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 14 |
Methylation of SCN9A in pancretic ductal adenocarcinoma | [ 7 ] | |||
Location |
Body (cg23533824) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.15E+00 | Statistic Test | p-value: 2.62E-02; Z-score: 1.10E+00 | ||
Methylation in Case |
7.41E-01 (Median) | Methylation in Control | 6.43E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 15 |
Methylation of SCN9A in pancretic ductal adenocarcinoma | [ 7 ] | |||
Location |
Body (cg03729603) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.20E+00 | Statistic Test | p-value: 4.03E-02; Z-score: 1.13E+00 | ||
Methylation in Case |
7.42E-01 (Median) | Methylation in Control | 6.19E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 16 |
Methylation of SCN9A in pancretic ductal adenocarcinoma | [ 7 ] | |||
Location |
3'UTR (cg20942867) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -2.84E+00 | Statistic Test | p-value: 8.73E-08; Z-score: -1.59E+00 | ||
Methylation in Case |
1.55E-01 (Median) | Methylation in Control | 4.39E-01 (Median) | ||
Studied Phenotype |
Pancretic ductal adenocarcinoma [ ICD-11: 2C10.0] | ||||
Experimental Material |
Patient tissue samples | ||||
Panic disorder |
5 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SCN9A in panic disorder | [ 8 ] | |||
Location |
5'UTR (cg03466415) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.07E+00 | Statistic Test | p-value: 2.71E-03; Z-score: -4.40E-01 | ||
Methylation in Case |
2.31E+00 (Median) | Methylation in Control | 2.46E+00 (Median) | ||
Studied Phenotype |
Panic disorder [ ICD-11: 6B01] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SCN9A in panic disorder | [ 8 ] | |||
Location |
5'UTR (cg13425422) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.14E+00 | Statistic Test | p-value: 3.23E-02; Z-score: -2.55E-01 | ||
Methylation in Case |
8.14E-01 (Median) | Methylation in Control | 9.27E-01 (Median) | ||
Studied Phenotype |
Panic disorder [ ICD-11: 6B01] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SCN9A in panic disorder | [ 8 ] | |||
Location |
TSS1500 (cg24789128) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 9.71E-01 | Statistic Test | p-value: 2.18E-02; Z-score: 5.01E-01 | ||
Methylation in Case |
-5.13E+00 (Median) | Methylation in Control | -5.28E+00 (Median) | ||
Studied Phenotype |
Panic disorder [ ICD-11: 6B01] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SCN9A in panic disorder | [ 8 ] | |||
Location |
Body (cg27357229) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -6.10E-01 | Statistic Test | p-value: 5.83E-06; Z-score: -6.25E-01 | ||
Methylation in Case |
-6.15E-01 (Median) | Methylation in Control | -3.75E-01 (Median) | ||
Studied Phenotype |
Panic disorder [ ICD-11: 6B01] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SCN9A in panic disorder | [ 8 ] | |||
Location |
Body (cg07296661) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.19E+00 | Statistic Test | p-value: 2.86E-04; Z-score: -7.36E-01 | ||
Methylation in Case |
1.63E+00 (Median) | Methylation in Control | 1.94E+00 (Median) | ||
Studied Phenotype |
Panic disorder [ ICD-11: 6B01] | ||||
Experimental Material |
Patient tissue samples | ||||
Papillary thyroid cancer |
7 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SCN9A in papillary thyroid cancer | [ 9 ] | |||
Location |
5'UTR (cg18745035) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 3.62E-03; Z-score: -4.85E-01 | ||
Methylation in Case |
9.03E-01 (Median) | Methylation in Control | 9.16E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SCN9A in papillary thyroid cancer | [ 9 ] | |||
Location |
5'UTR (cg13425422) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.02E+00 | Statistic Test | p-value: 4.15E-03; Z-score: -7.15E-01 | ||
Methylation in Case |
9.24E-01 (Median) | Methylation in Control | 9.38E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SCN9A in papillary thyroid cancer | [ 9 ] | |||
Location |
5'UTR (cg14794191) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 7.18E-03; Z-score: -5.76E-01 | ||
Methylation in Case |
9.15E-01 (Median) | Methylation in Control | 9.25E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SCN9A in papillary thyroid cancer | [ 9 ] | |||
Location |
TSS1500 (cg02056098) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.12E+00 | Statistic Test | p-value: 5.96E-03; Z-score: 1.06E+00 | ||
Methylation in Case |
6.01E-01 (Median) | Methylation in Control | 5.35E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SCN9A in papillary thyroid cancer | [ 9 ] | |||
Location |
TSS1500 (cg22199615) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.04E+00 | Statistic Test | p-value: 3.49E-02; Z-score: 2.78E-01 | ||
Methylation in Case |
1.16E-01 (Median) | Methylation in Control | 1.12E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SCN9A in papillary thyroid cancer | [ 9 ] | |||
Location |
Body (cg07296661) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 7.06E-03; Z-score: -3.17E-01 | ||
Methylation in Case |
9.27E-01 (Median) | Methylation in Control | 9.33E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 7 |
Methylation of SCN9A in papillary thyroid cancer | [ 9 ] | |||
Location |
Body (cg19320612) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.01E+00 | Statistic Test | p-value: 1.56E-02; Z-score: -3.03E-01 | ||
Methylation in Case |
9.22E-01 (Median) | Methylation in Control | 9.28E-01 (Median) | ||
Studied Phenotype |
Papillary thyroid cancer [ ICD-11: 2D10.1] | ||||
Experimental Material |
Patient tissue samples | ||||
Renal cell carcinoma |
6 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SCN9A in clear cell renal cell carcinoma | [ 10 ] | |||
Location |
TSS1500 (cg02056098) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.12E+00 | Statistic Test | p-value: 6.08E-03; Z-score: 1.83E+00 | ||
Methylation in Case |
8.00E-01 (Median) | Methylation in Control | 7.12E-01 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SCN9A in clear cell renal cell carcinoma | [ 10 ] | |||
Location |
TSS1500 (cg24789128) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.07E+00 | Statistic Test | p-value: 1.03E-02; Z-score: 2.62E-01 | ||
Methylation in Case |
2.85E-02 (Median) | Methylation in Control | 2.66E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 3 |
Methylation of SCN9A in clear cell renal cell carcinoma | [ 10 ] | |||
Location |
TSS1500 (cg02642021) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.06E+00 | Statistic Test | p-value: 3.34E-02; Z-score: 1.89E-01 | ||
Methylation in Case |
4.72E-02 (Median) | Methylation in Control | 4.45E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 4 |
Methylation of SCN9A in clear cell renal cell carcinoma | [ 10 ] | |||
Location |
TSS200 (cg18047082) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.17E+00 | Statistic Test | p-value: 1.01E-03; Z-score: 1.05E+00 | ||
Methylation in Case |
4.20E-02 (Median) | Methylation in Control | 3.58E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 5 |
Methylation of SCN9A in clear cell renal cell carcinoma | [ 10 ] | |||
Location |
TSS200 (cg22528044) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.07E+00 | Statistic Test | p-value: 1.81E-02; Z-score: 4.57E-01 | ||
Methylation in Case |
2.19E-02 (Median) | Methylation in Control | 2.05E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 6 |
Methylation of SCN9A in clear cell renal cell carcinoma | [ 10 ] | |||
Location |
TSS200 (cg00394494) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.07E+00 | Statistic Test | p-value: 2.47E-02; Z-score: 4.02E-01 | ||
Methylation in Case |
1.60E-02 (Median) | Methylation in Control | 1.49E-02 (Median) | ||
Studied Phenotype |
Renal cell carcinoma [ ICD-11: 2C90] | ||||
Experimental Material |
Patient tissue samples | ||||
Prostate cancer |
3 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Methylation of SCN9A in prostate cancer | [ 11 ] | |||
Location |
1stExon (cg13958974) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: 1.38E+00 | Statistic Test | p-value: 1.49E-02; Z-score: 1.78E+00 | ||
Methylation in Case |
6.42E-01 (Median) | Methylation in Control | 4.64E-01 (Median) | ||
Studied Phenotype |
Prostate cancer [ ICD-11: 2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Epigenetic Phenomenon 2 |
Methylation of SCN9A in prostate cancer | [ 11 ] | |||
Location |
3'UTR (cg06885175) | ||||
Epigenetic Type |
Methylation | Experiment Method | Infinium HumanMethylation450 BeadChip | ||
Methylation Fold Change |
Fold Change: -1.64E+00 | Statistic Test | p-value: 2.28E-02; Z-score: -6.16E+00 | ||
Methylation in Case |
2.78E-01 (Median) | Methylation in Control | 4.56E-01 (Median) | ||
Studied Phenotype |
Prostate cancer [ ICD-11: 2C82] | ||||
Experimental Material |
Patient tissue samples | ||||
Lymphoma |
1 Epigenetic Phenomena Related to This Phenotype | Click to Show/Hide the Full List | |||
Epigenetic Phenomenon 1 |
Significant hypermethylation of SCN9A in lymphoma than that in healthy individual | ||||
Studied Phenotype |
Lymphoma [ICD-11:2B30] | ||||
The Methylation Level of Disease Section Compare with the Healthy Individual |
p-value: 3.14E-25; Fold-change: 0.549555105; Z-score: 17.16148881 | ||||
DT methylation level in the diseased tissue of patients
DT methylation level in the normal tissue of healthy individuals
|
|||||
Please Click the above Thumbnail to View/Download the Methylation Barchart for All Samples | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.